Readline Intelligence

We have an extraordinary team linked by advanced infrastructure Novel enzyme design. We use in silico methods combing with wet-lab data for directional evolution of enzymes that can speed up the chemical processing of materials. AI-aided molecular design. We use state-of-the-art AI algorithms for designing new molecules for novel drugs and materials. Automated platform for experimental design. We design novel robotic platforms and software that can accelerate the experimental wet-lab work. In silico modeling of brain diseases. We build computational models and software for virtual brains and test the effect of novel drugs on various types of diseases.